HQH
Fiscal year ends September Quarters are offset from the calendar — Q1 is Oct–Dec

abrdn Healthcare Investors is a closed-end fund that seeks long-term capital appreciation by investing primarily in securities of healthcare companies. The fund invests primarily in equity and related securities, including common stock, preferred stock, convertible debt, limited partnership interests, and warrants, of U.S. and foreign companies principally engaged in the healthcare industries. The investment adviser targets companies believed to have significant potential for above-average long-term growth in revenues and earnings, possessing characteristics such as strong market positions, experienced management, and recognized technological expertise. The fund may invest in emerging growth healthcare companies, including those at the research and development stage with no marketable products, as well as large, well-known companies believed to be undervalued. The fund may invest in venture capital and other restricted securities, primarily in convertible preferred stock, which may include speculative debt securities. The fund may also invest in foreign securities, expected to be located primarily in Western Europe, Canada, and Japan, or U.S. issuers traded in foreign markets. The fund invests substantially in healthcare companies, defined as those where a significant portion of sales, earnings, or assets arise from healthcare products, services, or medical technology activities. The fund may also purchase and sell put or call options on permitted securities or correlated indices, and may engage in covered financial futures contracts and options on such futures.

Summarised from the fund's shareholder report or prospectus, filed Dec 2025

Industry Asset Management Homepage abrdnhqh.com
Sector Financial Services IR page —
Tags
closed-end fund, healthcare investing, venture capital, equity securities, convertible debt, options trading, foreign securities, long-term capital appreciation, abrdn Healthcare Investors
Press page —

Metrics

Valuation  
Market cap $ 1.105B
Market cap (USD) $ 1.105B
P/E 4.32
PEG —
P/BV 0.97
P/S 146.66
Discount/premium to NAV -6.3%
P/OCF —
P/FCF —
Dividend yield 11.6%
Turnover / mcap —
Returns  
ROE 9.2%
ROI 9.0%
ROIC -0.23%
Profit margin 1,309.0%
Growth  
Revenue growing No
Profits growing No
Revenue up 3y No
Revenue up 5y —
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable Yes
Margin expanding No
Buying back stock No
Diluting (TTM) Yes
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score 6.7%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2018
Revenue 7.533M 10.769M 58.118M -192.265M 157.103M — 5.619M
Net profit 98.613M 184.947M 56.335M -194.229M 155.176M — 108.886M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2018
Share price 18.46 18.62 — — — 20.62 22.7
Price performance 12m -0.01 0.2 — — — 0.12 —

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Prompts

abrdn Healthcare Investors Shares of Beneficial Interest (ticker HQH), listed in United States.

Company History

Date Change Detail
Nov 6, 2023 Renamed TEKLA HEALTHCARE INVESTORS → abrdn Healthcare Investors
Oct 15, 2014 Renamed H&Q HEALTHCARE INVESTORS → TEKLA HEALTHCARE INVESTORS

ETFs Holding abrdn Healthcare Investors Shares of Beneficial Interest

ETF Weight in ETF Shares Market value As of
FCEF 1.37% 50,836 $ 1.073M Nov 16, 2026